AU6858996A - Pharmaceutical compositions for the treatment of infectious diseases - Google Patents

Pharmaceutical compositions for the treatment of infectious diseases

Info

Publication number
AU6858996A
AU6858996A AU68589/96A AU6858996A AU6858996A AU 6858996 A AU6858996 A AU 6858996A AU 68589/96 A AU68589/96 A AU 68589/96A AU 6858996 A AU6858996 A AU 6858996A AU 6858996 A AU6858996 A AU 6858996A
Authority
AU
Australia
Prior art keywords
treatment
pharmaceutical compositions
infectious diseases
infectious
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68589/96A
Inventor
David J. Hinrichs
Michael Kevin Riscoe
Rolf Walter Winter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interlab Corp
Original Assignee
Interlab Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interlab Corp filed Critical Interlab Corp
Publication of AU6858996A publication Critical patent/AU6858996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU68589/96A 1995-08-28 1996-08-23 Pharmaceutical compositions for the treatment of infectious diseases Abandoned AU6858996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US520694 1990-05-08
US52069495A 1995-08-28 1995-08-28
PCT/US1996/013672 WO1997007790A1 (en) 1995-08-28 1996-08-23 Pharmaceutical compositions for the treatment of infectious diseases

Publications (1)

Publication Number Publication Date
AU6858996A true AU6858996A (en) 1997-03-19

Family

ID=24073701

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68589/96A Abandoned AU6858996A (en) 1995-08-28 1996-08-23 Pharmaceutical compositions for the treatment of infectious diseases

Country Status (2)

Country Link
AU (1) AU6858996A (en)
WO (1) WO1997007790A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
US6506798B1 (en) 1997-07-01 2003-01-14 Warner-Lambert Company 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
AR018698A1 (en) 1999-06-01 2001-11-28 Procter & Gamble METHOD FOR THE TREATMENT OF LOSS OF HAIR WHICH IS INCLUDED TO MANAGE A COMPOSITION THAT INCLUDES A COMPOUND WHICH DOES NOT AFFECT THE HEART
US6646005B1 (en) 1999-06-01 2003-11-11 The University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
EP1339702A1 (en) 2000-03-15 2003-09-03 Warner-Lambert Company 5-amide substituted diarylamines as mek inhibitors
US6586592B2 (en) 2000-06-20 2003-07-01 Pharmacia & Upjohn Company Bis-arylsulfones
PE20020063A1 (en) 2000-06-20 2002-01-30 Upjohn Co BIS-ARYLSULFONES AS LIGANDS OF THE 5-HT RECEPTOR
CA2473545A1 (en) 2002-01-23 2003-07-31 Warner-Lambert Company Llc N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
DOP2003000556A (en) 2002-01-23 2003-10-31 Warner Lambert Co ESTERES HYDROXAMATE ACID N- (4-PHENYL-REPLACED) -ANTRANILICO.
JP2007527418A (en) 2003-12-29 2007-09-27 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Composition for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
EP1753708B1 (en) 2004-01-20 2018-02-21 Brigham Young University Novel sirtuin activating compounds and methods for making the same
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
FR2944281B1 (en) * 2009-04-08 2011-07-29 Fabre Pierre Dermo Cosmetique RESORCINOL SULFUR DERIVATIVES, THEIR PREPARATION AND THEIR COSMETIC USES
CN106138018B (en) * 2015-04-02 2020-03-13 广州洁成生物科技有限公司 Application of hydroxybenzophenone in preparing antiviral and antitumor drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050440A (en) * 1960-10-13 1962-08-21 Velsicol Chemical Corp New fungicidal compositions of matter
US3947594A (en) * 1973-05-07 1976-03-30 Gaf Corporation 4-Halo-1-hydroxyanthraquinone containing fungicidal composition
US4311710A (en) * 1980-01-08 1982-01-19 Eli Lilly And Company Anticoccidial formulation and method
US4670265A (en) * 1983-07-22 1987-06-02 Sydiskis Robert J Aloe emodin and other anthraquinones and anthraquinone-like compounds from plants virucidal against herpes simplex viruses

Also Published As

Publication number Publication date
WO1997007790A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU6011496A (en) Improved pharmaceutical compositions for gene therapy
AU7572196A (en) Pharmaceutical formulations
AU6216296A (en) Pharmaceutical compositions
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
AU2549797A (en) Xanthone analogs for the treatment of infectious diseases
AU4048295A (en) Peptide medicaments for the treatment of disease
AU2027695A (en) Pharmaceutical composition for treating stoma-peripheral inflammation diseases
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
AU3107197A (en) Medicinal compositions for treating liver diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2027495A (en) Pharmaceutical composition for treating hemorrhoidal diseases
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU5274096A (en) Pharmaceutical compositions
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU5526196A (en) Compositions for the treatment of dandruff
AU3027692A (en) Compositions for the treatment of mammalian diseases
AU5699396A (en) Compositions for the treatment of skin conditions
AU6166396A (en) Complexes of modified lymphotoxins as pharmaceutical prepara tions
AU686084B3 (en) Pharmaceutical compositions for the treatment of depressive disorders
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye